Can scientist figure out how to control mutations that drive cancer?
Mutations, drugs drive cancer by blurring growth signals
Researchers control common cancer pathway in lab with pulses of light
August 31, 2018
University of California - San Francisco
Genetic mutations in a form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals, according to a new laboratory study. The research could have important implications for understanding and ultimately targeting the defective mechanisms underlying many human cancers.
231 day(s) ago